Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, +359

The Lancet

VaccinationVaccine SafetyPhase 1/2Vaccine DevelopmentPreliminary Report +5

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

Christoph Kreer, Matthias Zehner, Timm Weber, +25

Cell

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

Pedro M. Folegatti, Mustapha Bittaye, Amy Flaxman, +27

The Lancet Infectious Diseases

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

Till Koch, Christine Dahlke, Anahita Fathi, +22

The Lancet Infectious Diseases

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Alina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde, +26

Proceedings of the National Academy of Sciences

Nipah virus induces two inclusion body populations: Identification of novel inclusions at the plasma membrane

Marc Ringel, Anja Heiner, Laura Behner, +7

PLoS Pathogens

Virus StructureViral ReplicationMolecular VirologyPlasma MembraneMedicine +11

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

Sandro Halwe, Alexandra Kupke, Kanika Vanshylla, +25

Viruses

Viral PathogenesisImmunologyMonoclonal Neutralizing AntibodiesAntiviral DrugViral Structural Protein +14

Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients

Christoph Kreer, Matthias Zehner, Timm Weber, +24

Viral DiagnosticsHumoral ResponseImmunologyImmunodominanceSars-cov-2 Neutralizing Antibodies +17

Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies

Verena Krähling, Sandro Halwe, Cornelius Rohde, +13

Journal of Immunological Methods

VaccinationViral DiagnosticsSars-cov-2 SpikeVaccine TargetDiagnostic Test +12

Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription

Yuki Takamatsu, Verena Krähling, Larissa Kolesnikova, +6

mBio